NFSG
ABBV icon

Newbridge Financial Services Group’s AbbVie ABBV Stock Holding History

Newbridge Financial Services Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.28M Buy
9,066
+331
+4% +$71.2K 0.28% 74
2026
Q1 		$1.9M Buy
8,735
+122
+1% +$27.1K 0.31% 68
2025
Q4 		$1.97M Sell
8,613
-1,061
-11% -$242K 0.31% 69
2025
Q3 		$2.24M Buy
9,674
+31
+0.3% +$6.31K 0.33% 66
2025
Q2 		$1.79M Sell
9,643
-635
-6% -$118K 0.29% 73
2025
Q1 		$2.15M Sell
10,278
-642
-6% -$125K 0.52% 44
2024
Q4 		$1.94M Buy
10,920
+7,501
+219% +$1.38M 0.5% 44
2024
Q3 		$675K Sell
3,419
-511
-13% -$95.4K 0.24% 83
2024
Q2 		$674K Sell
3,930
-2,988
-43% -$495K 0.25% 79
2024
Q1 		$1.26M Buy
6,918
+541
+8% +$93.2K 0.55% 36
2023
Q4 		$988K Sell
6,377
-758
-11% -$111K 0.48% 38
2023
Q3 		$1.06M Sell
7,135
-359
-5% -$52.7K 0.53% 31
2023
Q2 		$1.01M Sell
7,494
-728
-9% -$107K 0.49% 30
2023
Q1 		$1.31M Buy
8,222
+113
+1% +$17.3K 0.7% 18
2022
Q4 		$1.31M Sell
8,109
-2
-0% -$307 0.76% 16
2022
Q3 		$1.09M Buy
8,111
+170
+2% +$24.4K 0.64% 16
2022
Q2 		$1.22M Buy
7,941
+640
+9% +$97.8K 0.75% 15
2022
Q1 		$1.18M Buy
7,301
+1,669
+30% +$242K 0.58% 27
2021
Q4 		$763K Buy
5,632
+411
+8% +$48.5K 0.36% 61
2021
Q3 		$563K Buy
5,221
+392
+8% +$44.8K 0.35% 62
2021
Q2 		$544K Buy
4,829
+288
+6% +$32.4K 0.33% 63
2021
Q1 		$491K Buy
4,541
+547
+14% +$58.5K 0.36% 62
2020
Q4 		$428K Sell
3,994
-400
-9% -$38.4K 0.35% 65
2020
Q3 		$385K Buy
+4,394
New +$414K 0.38% 61

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Newbridge Financial Services Group's ABBV Position: Q2 2026 in Review

Newbridge Financial Services Group increased its AbbVie (ABBV) stake by 3.8% in Q2 2026, buying an estimated $71.2K and bringing the position to 9,066 shares worth $2.28M. The position accounts for 0.28% of the portfolio, ranked #74.

Newbridge Financial Services Group first reported a position in ABBV in Q3 2020 and has held it in 24 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Newbridge Financial Services Group held 9,066 shares of AbbVie worth $2.28M as of Q2 2026.
  • Newbridge Financial Services Group bought 331 AbbVie shares in Q2 2026, an estimated $71.2K.
  • AbbVie made up 0.28% of Newbridge Financial Services Group's portfolio in Q2 2026, its #74 holding.
  • Newbridge Financial Services Group first reported a position in AbbVie in Q3 2020 and has held it in 24 quarters since.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Newbridge Financial Services Group's 13F filing for Q2 2026, filed 14 Aug 2026.